Getting a GRP on histone deacetylase inhibitor selectivity
Oncotarget
.
2017 Sep 13;8(45):78249-78250.
doi: 10.18632/oncotarget.20855.
eCollection 2017 Oct 3.
Authors
Husheng Ding
1
,
Cristina Correia
1
,
Scott Kaufmann
1
Affiliation
1
Scott Kaufmann: Department of Molecular Pharmacology and Experimental Therapeutics and Division of Oncology Research, Mayo Clinic, Rochester, MN, USA.
PMID:
29108219
PMCID:
PMC5667953
DOI:
10.18632/oncotarget.20855
No abstract available
Keywords:
BCL2 mutations; BIM upregulation; HDAC inhibitor; RAF1; RASGRP1.
Publication types
Editorial
Grants and funding
R01 CA166741/CA/NCI NIH HHS/United States